Dr. Ben Bikman

Yeah, yeah, so benbickman.com is kind of my education.

And then I also am a partner with Insulin IQ.

So we provide some coaching at insuliniq.com and then just straight education at benbickman.com.

And that's just Ben Bickman, PhD.

Yeah, I try to be active on social media, but you know how it is.

It's like a black hole.

The more I give it, the more it takes.

And so I tend to have a bit of a light touch.

Same, same.

Well, thank you so much, Ben.

Yeah, there are a lot of ways we could define metabolic health and even overall health. For me, it is a matter of insulin resistance. The problem with defining a lot of cardiometabolic outcomes is that we have a very glucose-centric paradigm. And this has led conventional clinical care to focus almost exclusively on glucose as the primary metabolic marker.

Yeah, there are a lot of ways we could define metabolic health and even overall health. For me, it is a matter of insulin resistance. The problem with defining a lot of cardiometabolic outcomes is that we have a very glucose-centric paradigm. And this has led conventional clinical care to focus almost exclusively on glucose as the primary metabolic marker.

Yeah, there are a lot of ways we could define metabolic health and even overall health. For me, it is a matter of insulin resistance. The problem with defining a lot of cardiometabolic outcomes is that we have a very glucose-centric paradigm. And this has led conventional clinical care to focus almost exclusively on glucose as the primary metabolic marker.

And yet, underlying the changes in glucose that could be happening over time is the humble little hormone insulin who's just overlooked, you know, just kind of crying out for some attention sitting in the corner. But to sort of bring these ideas together, we look at glucose all the time.

And yet, underlying the changes in glucose that could be happening over time is the humble little hormone insulin who's just overlooked, you know, just kind of crying out for some attention sitting in the corner. But to sort of bring these ideas together, we look at glucose all the time.

And yet, underlying the changes in glucose that could be happening over time is the humble little hormone insulin who's just overlooked, you know, just kind of crying out for some attention sitting in the corner. But to sort of bring these ideas together, we look at glucose all the time.

And any blood test when someone goes into the clinic, they're going to measure glucose and they're going to measure hemoglobin A1c. And it could be normal and normal and normal for years, but the person has high blood pressure, they're gaining weight, they have migraine headaches.

And any blood test when someone goes into the clinic, they're going to measure glucose and they're going to measure hemoglobin A1c. And it could be normal and normal and normal for years, but the person has high blood pressure, they're gaining weight, they have migraine headaches.

And any blood test when someone goes into the clinic, they're going to measure glucose and they're going to measure hemoglobin A1c. And it could be normal and normal and normal for years, but the person has high blood pressure, they're gaining weight, they have migraine headaches.

And so there's no even suspicion that the glucose could not only be contributing to these problems, but that there is any problem, metabolically speaking. But while the glucose levels have stayed at a normal range during all these years, decades even, the hormone insulin has been the canary in the coal mine. It has been increasing steadily year over year over year.